---
title: "PCVX SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Vaxcyte (PCVX), with links to the SEC filings."
url: "https://tradytics.com/research/PCVX/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=PCVX&v=stock-11994868"
---

# PCVX financial statements and SEC filings

## PCVX annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | – | -$923.67M | -$766.63M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2024-12-31 | – | -$569.55M | -$463.93M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2023-12-31 | – | -$468.04M | -$402.27M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2022-12-31 | – | -$232.26M | -$223.49M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/0001649094-25-000028-index.htm) |
| 2021-12-31 | – | -$103.67M | -$100.08M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/0000950170-24-021145-index.htm) |
| 2020-12-31 | – | -$89.58M | -$89.22M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/0000950170-23-004654-index.htm) |

## PCVX annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $3.00B | $317.21M | $2.69B | [10-Q](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000054/0001649094-26-000054-index.htm) |
| 2024-12-31 | $3.51B | $205.50M | $3.31B | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2023-12-31 | $1.41B | $167.45M | $1.24B | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/0001649094-25-000028-index.htm) |
| 2022-12-31 | $1.01B | $52.56M | $953.61M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/0000950170-24-021145-index.htm) |
| 2021-12-31 | $324.34M | $40.32M | $284.02M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/0000950170-23-004654-index.htm) |
| 2020-12-31 | $392.83M | $46.98M | $345.84M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/0000950170-22-002281-index.htm) |

## PCVX annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$655.58M | -$13.71M | $2.01M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2024-12-31 | -$452.63M | -$22.43M | $2.45B | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2023-12-31 | -$296.79M | -$16.06M | $639.81M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm) |
| 2022-12-31 | -$170.60M | -$5.84M | $861.55M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/0001649094-25-000028-index.htm) |
| 2021-12-31 | -$121.39M | -$6.55M | $17.80M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/0000950170-24-021145-index.htm) |
| 2020-12-31 | -$46.63M | -$1.16M | $374.87M | [10-K](https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/0000950170-23-004654-index.htm) |

- [PCVX stock research](https://tradytics.com/research/PCVX)
- [PCVX financial summary](https://tradytics.com/research/PCVX/financials)
- [Read the data without JavaScript](https://tradytics.com/research/PCVX/fundamentals?snapshot=1)
